david wyld
david wyld
Director Medical Oncology Royal Brisbane and Womens Hospital
Verified email at health.qld.gov.au
TitleCited byYear
Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer
International Adjuvant Lung Cancer Trial Collaborative Group
New England Journal of Medicine 350 (4), 351-360, 2004
24092004
Detection of colorectal cancer cells in peripheral blood by reverse‐transcriptase polymerase chain reaction for cytokeratin 20
DK Wyld, P Selby, TJ Perren, SK Jonas, TG Allen‐Mersh, J Wheeldon, ...
International journal of cancer 79 (3), 288-293, 1998
1861998
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ...
The lancet oncology 8 (7), 603-612, 2007
1332007
Cisplatin‐based therapy: a neurological and neuropsychological review
L Troy, K McFarland, S Littman‐Power, BJ Kelly, ET Walpole, D Wyld, ...
Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2000
1242000
Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and KRAS-Specific Results of the NCIC CTG and …
HJ Au, CS Karapetis, CJ O'Callaghan, D Tu, MJ Moore, JR Zalcberg, ...
Journal of Clinical Oncology 27 (11), 1822-1828, 2009
1022009
Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
RA Herbertson, NC Tebbutt, FT Lee, DJ MacFarlane, B Chappell, ...
Clinical Cancer Research 15 (21), 6709-6715, 2009
612009
Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme
AB Francesconi, S Dupre, M Matos, D Martin, BG Hughes, DK Wyld, ...
Journal of Clinical Neuroscience 17 (8), 970-974, 2010
592010
A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma
R Kefford, JMN Beith, GA Van Hazel, M Millward, JM Trotter, DK Wyld, ...
Investigational new drugs 25 (3), 247-252, 2007
542007
A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma
R Kefford, JMN Beith, GA Van Hazel, M Millward, JM Trotter, DK Wyld, ...
Investigational new drugs 25 (3), 247-252, 2007
542007
Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study
MJ Newton, SC Hayes, M Janda, PM Webb, A Obermair, EG Eakin, ...
BMC cancer 11 (1), 389, 2011
432011
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates
BE Kiely, AJ Martin, MHN Tattersall, AK Nowak, D Goldstein, ...
Journal of clinical oncology 31 (28), 3565-3571, 2013
352013
Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer–a population-based study
S Jordan, C Steer, A DeFazio, M Quinn, A Obermair, M Friedlander, ...
Gynecologic oncology 129 (2), 310-317, 2013
332013
Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer
TR Newton, PG Parsons, DJ Lincoln, MC Cummings, DK Wyld, PM Webb, ...
International journal of cancer 119 (4), 875-883, 2006
302006
Respiratory bronchiolitis‐associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy
M Flower, L Nandakumar, M Singh, D Wyld, M Windsor, D Fielding
Respirology case reports 5 (3), e00230, 2017
272017
Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study
A Molassiotis, P Yates, Q Li, WKW So, K Pongthavornkamol, P Pittayapan, ...
Annals of Oncology 28 (10), 2552-2558, 2017
262017
Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent
JD Lickliter, AB Francesconi, G Smith, M Burge, A Coulthard, S Rose, ...
British journal of cancer 103 (5), 597-606, 2010
262010
Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer
M Friedlander, M Buck, D Wyld, M Findlay, B Fitzharris, P De Souza, ...
International Journal of Gynecologic Cancer 17 (2), 350-358, 2007
262007
A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services
VL Beesley, M Janda, D Goldstein, H Gooden, ND Merrett, DL O'Connell, ...
Psycho‐Oncology 25 (2), 150-157, 2016
252016
Co-administration of RANKL and CTLA4 antibodies enhances lymphocyte-mediated antitumor immunity in mice
E Ahern, H Harjunpää, D Barkauskas, S Allen, K Takeda, H Yagita, ...
Clinical Cancer Research 23 (19), 5789-5801, 2017
242017
Describing patterns of care in pancreatic cancer: a population-based study
EA Burmeister, DL O'Connell, VL Beesley, D Goldstein, HM Gooden, ...
Pancreas 44 (8), 1259-1265, 2015
242015
The system can't perform the operation now. Try again later.
Articles 1–20